BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 22081787)

  • 1. Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma.
    Tai HC; Huang HY; Lee SW; Lin CY; Sheu MJ; Chang SL; Wu LC; Shiue YL; Wu WR; Lin CM; Li CF
    J Clin Pathol; 2012 Mar; 65(3):248-53. PubMed ID: 22081787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma.
    Chen J; Li S; Xiao Y; Zou X; Zhang X; Zhu M; Cai M; Xie D
    BMC Cancer; 2017 Dec; 17(1):846. PubMed ID: 29237424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma.
    Zhang Y; Zhu Y; Wang J; Xu Y; Wang Z; Liu Y; Di X; Feng L; Zhang Y
    Cancer Immunol Immunother; 2022 Mar; 71(3):675-688. PubMed ID: 34342668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer.
    Wang X; Sheu JJ; Lai MT; Yin-Yi Chang C; Sheng X; Wei L; Gao Y; Wang X; Liu N; Xie W; Chen CM; Ding WY; Sun L
    Biomedicine (Taipei); 2018 Mar; 8(1):4. PubMed ID: 29480799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers.
    Hsiao YW; Chi JY; Li CF; Chen LY; Chen YT; Liang HY; Lo YC; Hong JY; Chuu CP; Hung LY; Du JY; Chang WC; Wang JM
    Clin Transl Med; 2022 Jan; 12(1):e724. PubMed ID: 35090088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of ISWI chromatin remodeling complexes in cancer.
    Li Y; Gong H; Wang P; Zhu Y; Peng H; Cui Y; Li H; Liu J; Wang Z
    J Exp Clin Cancer Res; 2021 Nov; 40(1):346. PubMed ID: 34736517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RSF1 in cancer: interactions and functions.
    Cai G; Yang Q; Sun W
    Cancer Cell Int; 2021 Jun; 21(1):315. PubMed ID: 34147108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSF1 requires CEBP/β and hSNF2H to promote IL-1β-mediated angiogenesis: the clinical and therapeutic relevance of RSF1 overexpression and amplification in myxofibrosarcomas.
    Li CF; Chan TC; Wang CI; Fang FM; Lin PC; Yu SC; Huang HY
    Angiogenesis; 2021 Aug; 24(3):533-548. PubMed ID: 33496909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RSF-1 siRNA Enhances Tumor Radiosensitivity in Cervical Cancer via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis.
    Tian J; Kong E; Wang X; Xie Z; Chang CY; Sheu JJ; Hao Q; Sun L
    Onco Targets Ther; 2020; 13():3061-3071. PubMed ID: 32308437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rsf‑1 regulates malignant melanoma cell viability and chemoresistance via NF‑κB/Bcl‑2 signaling.
    He J; Fu L; Li Q
    Mol Med Rep; 2019 Oct; 20(4):3487-3498. PubMed ID: 31485613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway.
    Liu F; Tai Y; Ma J
    Cancer Biol Ther; 2018 Jun; 19(6):534-542. PubMed ID: 29565706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Translational Regulation of the RSF1 Chromatin Remodeler under DNA Damage.
    Min S; Choi YW; Yun H; Jo S; Ji JH; Cho H
    Mol Cells; 2018 Feb; 41(2):127-133. PubMed ID: 29385673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Rsf-1 correlates with poor survival and promotes invasion in non-small cell lung cancer.
    Zhang X; Fu L; Xue D; Zhang X; Hao F; Xie L; He J; Gai J; Liu Y; Xu H; Li Q; Wang E
    Virchows Arch; 2017 May; 470(5):553-560. PubMed ID: 28289901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma.
    Liu Y; Li G; Liu C; Tang Y; Zhang S
    J Cancer; 2017; 8(3):354-362. PubMed ID: 28261335
    [No Abstract]   [Full Text] [Related]  

  • 16. Epigenomic regulation of oncogenesis by chromatin remodeling.
    Kumar R; Li DQ; Müller S; Knapp S
    Oncogene; 2016 Aug; 35(34):4423-36. PubMed ID: 26804164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies.
    Wu J; Hu L; Wu F; He T
    Int J Clin Exp Med; 2015; 8(2):1944-55. PubMed ID: 25932123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance.
    Yang YI; Ahn JH; Lee KT; Shih IeM; Choi JH
    Cancer Res; 2014 Apr; 74(8):2258-69. PubMed ID: 24566868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance.
    Lan J; Tai HC; Lee SW; Chen TJ; Huang HY; Li CF
    Tumour Biol; 2014 Jan; 35(1):161-9. PubMed ID: 23897555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.